You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API dolutegravir sodium and lamivudine

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing dolutegravir sodium and lamivudine

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
ViiV Healthcare Company	DOVATO	dolutegravir sodium and lamivudine	49702-246	CELLULOSE, MICROCRYSTALLINE	2031-01-24
ViiV Healthcare Company	DOVATO	dolutegravir sodium and lamivudine	49702-246	HYPROMELLOSE	2031-01-24
ViiV Healthcare Company	DOVATO	dolutegravir sodium and lamivudine	49702-246	MAGNESIUM STEARATE	2031-01-24
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for dolutegravir sodium and lamivudine

Excipient focus: CELLULOSE, MICROCRYSTALLINE

dolutegravir sodium and lamivudine drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

dolutegravir sodium and lamivudine drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

dolutegravir sodium and lamivudine drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

dolutegravir sodium and lamivudine drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL

dolutegravir sodium and lamivudine drug variants containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE K30

dolutegravir sodium and lamivudine drug variants containing POVIDONE K30

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing POVIDONE K30

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

dolutegravir sodium and lamivudine drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

dolutegravir sodium and lamivudine drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

dolutegravir sodium and lamivudine drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
ViiV Healthcare Company	dolutegravir sodium and lamivudine	49702-246
>Company	>Ingredient	>NDC

dolutegravir sodium and lamivudine drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.